1. Chang HC, Kuo L, Sung SH, Niu DM, Yu WC. Prognostic Implications of Left Ventricular Hypertrophy and Mechanical Function in Fabry Disease: A Longitudinal Cohort Study. J Am Soc Echocardiogr. 2024;37(8):787-796.
2. Chang HC, Tseng CH, Huang WM, Lee CW, Yu WC, Cheng HM, Chiang CE, Chen CH, Sung SH. Supranormal Left Ventricular Ejection Fraction, Concentric Remodeling, and Long-Term Survival. JACC: Asia. 2024;4(12):928–937.
3. Chang HC, Chen YY, Kuo TT, Lin YJ, Chien KL, Chang HY, Hung CL, Chung FP. Sodium Glucose Transporter 2 Inhibitors Versus Metformin on Cardiovascular and Renal Outcomes in Patients With Diabetes With Low Cardiovascular Risk: A Nationwide Cohort Study. J Am Heart Assoc. 2024;13(8):e032397.
4. Chang HC, Kuo L, Sung SH, Weng CY, Chen CK, Niu DM, Chen SA, Yu WC. Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification. J Am Heart Assoc. 2023;12(1):e027041.
5. Chang HC, Kuo TT, Chen YY, Lin YJ, Chang HY, Hung CL, Chung FP. Sodium-Glucose Cotransporter 2 Inhibitors in Cardiovascular and Renal Outcomes in Patients With Diabetes but Without Established Cardiovascular Disease: A Nationwide Population-Based Cohort Study. Diabetes Care. 2022;45(9):129-130.

限於篇幅,以上謹為代表著作